Scholarlink

Background <p>Cholangiocarcinoma (CCA) is a rare malignancy originating from the hepatobiliary epithelium, accounting for 3–5% of all gastrointestinal cancers worldwide. CCA is notoriously difficult to diagnose and is associated with a high mortality rate. While most cases lack identifiable predisposing factors, emerging evidence suggests that molecular therapies targeting fibroblast growth factor receptor and isocitrate dehydrogenase show promise for specific CCA patients.</p> Methods <p>This study employed a series of comprehensive bioinformatics analyses, survival analyses, immunohistochemistry, and drug sensitivity screening.</p> Results <p>We decoded the dynamic changes in cell populations between cholangiocarcinoma and paired healthy tissues, revealing that JAG1-NOTCH signaling significantly contributes to CCA pathogenesis. Higher NOTCH2 expression was correlated with poor prognosis and validated as a proliferative promoter in cell lines. Additionally, we identified four potential drugs targeting NOTCH2.</p> Conclusions <p>These findings provide new insights into the molecular basis of NOTCH2-mediated promotion of tumor activity and suggest NOTCH2 as a potential therapeutic target for CCA treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification of NOTCH2 as a prognostic marker for cholangiocarcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月2日

查看全文
  • Fengxiao Sun,
  • Meina Li,
  • Kang Fu,
  • Junzhe Su,
  • Lin Sun,
  • Yuan Ma,
  • Xiao Hu

摘要

Background

Cholangiocarcinoma (CCA) is a rare malignancy originating from the hepatobiliary epithelium, accounting for 3–5% of all gastrointestinal cancers worldwide. CCA is notoriously difficult to diagnose and is associated with a high mortality rate. While most cases lack identifiable predisposing factors, emerging evidence suggests that molecular therapies targeting fibroblast growth factor receptor and isocitrate dehydrogenase show promise for specific CCA patients.

Methods

This study employed a series of comprehensive bioinformatics analyses, survival analyses, immunohistochemistry, and drug sensitivity screening.

Results

We decoded the dynamic changes in cell populations between cholangiocarcinoma and paired healthy tissues, revealing that JAG1-NOTCH signaling significantly contributes to CCA pathogenesis. Higher NOTCH2 expression was correlated with poor prognosis and validated as a proliferative promoter in cell lines. Additionally, we identified four potential drugs targeting NOTCH2.

Conclusions

These findings provide new insights into the molecular basis of NOTCH2-mediated promotion of tumor activity and suggest NOTCH2 as a potential therapeutic target for CCA treatment.